The ABL90 FLEX and ABL90 FLEX PLUS analyzers are intended for use by… — Class II medical device recall Z-0190-2027
Ongoing recall by Radiometer Medical ApS, reported 2026-10-21, distributed nationwide. In vitro diagnostic analyzer had a risk of potentially inaccurate results requiring changes to instructions fo
| Recall number | Z-0190-2027 |
|---|---|
| Product type | Medical device |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Radiometer Medical ApS, Bronshoj, Denmark |
| Recall initiated | 2026-08-18 |
| Classified | 2026-10-15 |
| Reported by FDA | 2026-10-21 |
| Distributed | Nationwide (US) |
| Quantity | 5,395 |
| UPC / GTIN / UDI-DI | 05700693930909, 05700693930923 |
Product
The ABL90 FLEX and ABL90 FLEX PLUS analyzers are intended for use by trained technologists, nurses, physicians and therapists. It is intended for use in a laboratory environment, near patient or point-of-care setting. These tests are only performed under a physician's order.
Reason for recall
In vitro diagnostic analyzer had a risk of potentially inaccurate results requiring changes to instructions for use and: 1) Sample types, including whole blood samples no longer suitable for testing FHbF and ctBil, 2) Reportable ranges for some parameters, 3) Analyzer configuration, and 4) limitations and warnings.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/Z-0190-2027. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-10-27. Not affiliated with or endorsed by FDA. Not medical or legal advice.